Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Characterization of Human α4β2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells

J. Brek Eaton, Jian-Hong Peng, Katherine M. Schroeder, Andrew A. George, John D. Fryer, Chandra Krishnan, Lori Buhlman, Yen-Ping Kuo, Ortrud Steinlein and Ronald J. Lukas
Molecular Pharmacology December 2003, 64 (6) 1283-1294; DOI: https://doi.org/10.1124/mol.64.6.1283
J. Brek Eaton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-Hong Peng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine M. Schroeder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew A. George
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Fryer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandra Krishnan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori Buhlman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yen-Ping Kuo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ortrud Steinlein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald J. Lukas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 64 no. 6 1283-1294
DOI 
https://doi.org/10.1124/mol.64.6.1283
PubMed 
14645658

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 21, 2003
  • Accepted July 30, 2003
  • Published online November 26, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. Brek Eaton,
  2. Jian-Hong Peng,
  3. Katherine M. Schroeder,
  4. Andrew A. George,
  5. John D. Fryer1,
  6. Chandra Krishnan,
  7. Lori Buhlman,
  8. Yen-Ping Kuo,
  9. Ortrud Steinlein and
  10. Ronald J. Lukas
  1. Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona (J.B.E., J.-H.P., K.M.S., A.A.G., J.D.F., C.K., L.B., Y.-P.K., R.J.L.); and Institute for Human Genetics, Rheinische Friedrich-Wilhelms-Universitat, Bonn, Germany (O.S.)
  1. Address correspondence to:
    Dr. Ronald J. Lukas, Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013. E-mail: rlukas{at}chw.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2003 to May 2022

AbstractFullPdf
Nov 2003231621
Dec 20037411594
Jan 2004347954
Feb 2004166352
Mar 2004258433
Apr 2004153829
May 200494223
Jun 2004284726
Jul 2004214015
Aug 2004174510
Sep 2004134216
Oct 200423375
Nov 2004204310
Dec 2004206437
Jan 2005324822
Feb 2005206426
Mar 2005133225
Apr 200572314
May 2005103223
Jun 200573120
Jul 200573023
Aug 200553516
Sep 200552619
Oct 200532714
Nov 2005114819
Dec 200581911
Jan 2006205413
Feb 2006134613
Mar 200663214
Apr 200622913
May 200622512
Jun 200652413
Jul 200692211
Aug 20065156
Sep 200631815
Oct 200672712
Nov 200662121
Dec 20065157
Jan 200772314
Feb 200762016
Mar 200731811
Apr 200741811
May 200742216
Jun 200741614
Jul 200751212
Aug 20075199
Sep 20071148
Oct 200772315
Nov 200781513
Dec 2007295
Jan 200841512
Feb 200842218
Mar 200843319
Apr 2008103319
May 2008112816
Jun 2008112210
Jul 2008193227
Aug 200823193
Sep 200812268
Oct 200816308
Nov 200818185
Dec 200813124
Jan 20097126
Feb 200961115
Mar 2009271987
Apr 20098114
May 20090115
Jun 200992210
Jul 20099124
Aug 2009676
Sep 20095177
Oct 20097148
Nov 20092116
Dec 20095611
Jan 20109159
Feb 20101286
Mar 20108173
Apr 20101596
May 2010131410
Jun 201016158
Jul 201017129
Aug 20101285
Sep 20101396
Oct 20107186
Nov 201019197
Dec 20109155
Jan 201112207
Feb 201110194
Mar 2011162810
Apr 201161215
May 2011142317
Jun 2011171518
Jul 2011161110
Aug 201151813
Sep 201161813
Oct 2011112516
Nov 2011142913
Dec 201182813
Jan 20126248
Feb 2012152716
Mar 201213117
Apr 201213139
May 201292713
Jun 20124178
Jul 2012112112
Aug 2012192313
Sep 201211209
Oct 2012142511
Nov 201211257
Dec 2012122612
Jan 2013233112
Feb 2013222012
Mar 201318288
Apr 201319125
May 2013152714
Jun 201331914
Jul 20134128
Aug 20134152
Sep 2013261211
Oct 20138184
Nov 20135216
Dec 201310128
Jan 20141091
Feb 201451810
Mar 201462210
Apr 20147236
May 201412188
Jun 20145146
Jul 20147255
Aug 20144144
Sep 20149158
Oct 20149154
Nov 2014182110
Dec 2014171220
Jan 2015142311
Feb 201515203
Mar 20158664
Apr 201593612
May 2015153012
Jun 201511286
Jul 2015152211
Aug 201521334
Sep 20158145
Oct 20156163
Nov 2015102613
Dec 20156187
Jan 201616124
Feb 201616107
Mar 201652214
Apr 201621914
May 20162188
Jun 201661819
Jul 20164267
Aug 201642813
Sep 201662610
Oct 20163226
Nov 20163326
Dec 20160196
Jan 20171313
Feb 20171272
Mar 20173235
Apr 20173282
May 20174297
Jun 201722010
Jul 20174447
Aug 20173312
Sep 20174185
Oct 20170195
Nov 20170368
Dec 20170156
Jan 201801610
Feb 20180145
Mar 20180253
Apr 20181577
May 201805522
Jun 20180337
Jul 20180166
Aug 20181244
Sep 20181435
Oct 20180619
Nov 201801067
Dec 201866130
Jan 20196522
Feb 20195982
Mar 20193220
Apr 20194881
May 20191960
Jun 20191354
Jul 20193138
Aug 20191552
Sep 20192821
Oct 20191031
Nov 20192731
Dec 20191432
Jan 20202151
Feb 20201300
Mar 20201732
Apr 20201200
May 20201732
Jun 2020943
Jul 20202622
Aug 20201004
Sep 2020820
Oct 2020761
Nov 2020912
Dec 20202041
Jan 202120203
Feb 20211192
Mar 20212572
Apr 20211571
May 20211592
Jun 20218131
Jul 20211561
Aug 2021380
Sep 20211470
Oct 2021730
Nov 20211630
Dec 20212430
Jan 20222420
Feb 20221220
Mar 20221080
Apr 20223240
May 2022852

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 64 (6)
Molecular Pharmacology
Vol. 64, Issue 6
1 Dec 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of Human α4β2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Characterization of Human α4β2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells

J. Brek Eaton, Jian-Hong Peng, Katherine M. Schroeder, Andrew A. George, John D. Fryer, Chandra Krishnan, Lori Buhlman, Yen-Ping Kuo, Ortrud Steinlein and Ronald J. Lukas
Molecular Pharmacology December 1, 2003, 64 (6) 1283-1294; DOI: https://doi.org/10.1124/mol.64.6.1283

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Characterization of Human α4β2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells

J. Brek Eaton, Jian-Hong Peng, Katherine M. Schroeder, Andrew A. George, John D. Fryer, Chandra Krishnan, Lori Buhlman, Yen-Ping Kuo, Ortrud Steinlein and Ronald J. Lukas
Molecular Pharmacology December 1, 2003, 64 (6) 1283-1294; DOI: https://doi.org/10.1124/mol.64.6.1283
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics